Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones

Leerink Partners Remains Sidelined on Agios Pharma (AGIO) - PT to $56

February 19, 2016 7:30 AM EST

Leerink Partners maintained a Market Perform rating on Agios Pharma (NASDAQ: AGIO), and cut the price target to $56.00 (from $62.00), following the company's 4Q earnings call. AGIO provided a number of incremental pipeline updates. Leerink sees the announced AG-348 and AG-519 data at EHA in June and... More

Agios Pharma (AGIO) Reports Q4 Loss of $1.08/Share

February 18, 2016 7:15 AM EST

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.08), versus ($0.76) reported last year. Revenue for the quarter came in at $6.22 million, versus $14.64 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

... More